Literature DB >> 22132891

Proteomics plus genomics approaches in primary immunodeficiency: the case of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome.

D Zennaro1, E Scala, D Pomponi, E Caprini, D Arcelli, E Gambineri, G Russo, A Mari.   

Abstract

Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) is a rare syndrome due to a mutation in the forkhead box protein 3 gene (FOXP3) leading to an impaired regulatory T cell (T(reg) ) activity associated both with skewed T helper type 2 (Th2) response and autoreactive phenomena. The purpose of this study was to describe a combined proteomics and genomics approach to comprehensively evaluate clinical and immunological phenotypes of patients affected by IPEX. T cell receptor (TCR)-Vβ repertoire and peripheral blood lymphocytes phenotype from three brothers affected by IPEX were studied by flow cytometry. Specific immunoglobulin (Ig)E were evaluated by means of an allergenic molecules microarray [immuno solid-phase allergen chip (ISAC)]. Total RNA was extracted and hybridized to Affymetrix oligonucleotide arrays to obtain quantitative gene-expression levels. No FOXP3 protein was detectable within CD127(-) CD25(high) CD4(+) T cells from peripheral blood. A T cell-naive phenotype (CD62L(+) CD45R0(-)) associated with a reduction of both CD26 and CD7 expression and a TCR-Vβ 8 and 22 family expansions were found. B lymphocytes were mainly CD5(+) (B1) cells expressing a naive phenotype (tcl1(+) CD27(-)). The three IPEX patients had severe food allergy and specific IgE reactivity to cow's milk allergens, a hen's egg allergen and a wheat allergen. Gene expression profile analysis revealed a dysregulation associated mainly with Th1/Th2 pathways. The multiplexing evaluation reported in this study represents a comprehensive approach in the assessment of genetic conditions affecting the immune system such as the IPEX syndrome, paving the way for the development of diagnostic tools to improve the standard clinical and immunological profiling of the disease.
© 2011 The Authors. Clinical and Experimental Immunology © 2011 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22132891      PMCID: PMC3248093          DOI: 10.1111/j.1365-2249.2011.04492.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation.

Authors:  O Baud; O Goulet; D Canioni; F Le Deist; I Radford; D Rieu; S Dupuis-Girod; N Cerf-Bensussan; M Cavazzana-Calvo; N Brousse; A Fischer; J L Casanova
Journal:  N Engl J Med       Date:  2001-06-07       Impact factor: 91.245

Review 2.  IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena.

Authors:  C L Bennett; H D Ochs
Journal:  Curr Opin Pediatr       Date:  2001-12       Impact factor: 2.856

3.  A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA-->AAUGAA) leads to the IPEX syndrome.

Authors:  C L Bennett; M E Brunkow; F Ramsdell; K C O'Briant; Q Zhu; R L Fuleihan; A O Shigeoka; H D Ochs; P F Chance
Journal:  Immunogenetics       Date:  2001-08       Impact factor: 2.846

4.  Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment.

Authors:  Reinhard Hiller; Sylvia Laffer; Christian Harwanegg; Martin Huber; Wolfgang M Schmidt; Anna Twardosz; Bianca Barletta; Wolf M Becker; Kurt Blaser; Heimo Breiteneder; Martin Chapman; Reto Crameri; Michael Duchêne; Fatima Ferreira; Helmut Fiebig; Karin Hoffmann-Sommergruber; Te Piao King; Tamara Kleber-Janke; Viswanath P Kurup; Samuel B Lehrer; Jonas Lidholm; Ulrich Müller; Carlo Pini; Gerald Reese; Otto Scheiner; Annika Scheynius; Horng-Der Shen; Susanne Spitzauer; Roland Suck; Ines Swoboda; Wayne Thomas; Raffaela Tinghino; Marianne Van Hage-Hamsten; Tuomas Virtanen; Dietrich Kraft; Manfred W Müller; Rudolf Valenta
Journal:  FASEB J       Date:  2002-01-14       Impact factor: 5.191

5.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.

Authors:  C L Bennett; J Christie; F Ramsdell; M E Brunkow; P J Ferguson; L Whitesell; T E Kelly; F T Saulsbury; P F Chance; H D Ochs
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

Review 6.  Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome.

Authors:  R S Wildin; S Smyk-Pearson; A H Filipovich
Journal:  J Med Genet       Date:  2002-08       Impact factor: 6.318

7.  The origin of FOXP3-expressing CD4+ regulatory T cells: thymus or periphery.

Authors:  Shimon Sakaguchi
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

Review 8.  Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis.

Authors:  Eleonora Gambineri; Troy R Torgerson; Hans D Ochs
Journal:  Curr Opin Rheumatol       Date:  2003-07       Impact factor: 5.006

9.  X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy.

Authors:  R S Wildin; F Ramsdell; J Peake; F Faravelli; J L Casanova; N Buist; E Levy-Lahad; M Mazzella; O Goulet; L Perroni; F D Bricarelli; G Byrne; M McEuen; S Proll; M Appleby; M E Brunkow
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

10.  Regulation of TCL1 expression in B- and T-cell lymphomas and reactive lymphoid tissues.

Authors:  M G Narducci; E Pescarmona; C Lazzeri; S Signoretti; A M Lavinia; D Remotti; E Scala; C D Baroni; A Stoppacciaro; C M Croce; G Russo
Journal:  Cancer Res       Date:  2000-04-15       Impact factor: 12.701

View more
  11 in total

Review 1.  Multicentric reticulohistiocytosis: a critical review.

Authors:  Carlo Selmi; Adam Greenspan; Arthur Huntley; M Eric Gershwin
Journal:  Curr Rheumatol Rep       Date:  2015-06       Impact factor: 4.592

2.  Circulating L-selectin expressing-T cell subsets correlate with the severity of Foxp3 deficiency autoimmune disease.

Authors:  Yuying Liu; Thomas K Hoang; Ting Wang; Baokun He; Dat Q Tran; Jain Zhou; Nina Tatevian; J Marc Rhoads
Journal:  Int J Clin Exp Pathol       Date:  2016-02-15

3.  T follicular regulatory cells and IL-10 promote food antigen-specific IgE.

Authors:  Markus M Xie; Qiang Chen; Hong Liu; Kai Yang; Byunghee Koh; Hao Wu; Soheila J Maleki; Barry K Hurlburt; Joan Cook-Mills; Mark H Kaplan; Alexander L Dent
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

Review 4.  Emerging therapies for food allergy.

Authors:  Corinne A Keet; Robert A Wood
Journal:  J Clin Invest       Date:  2014-05-01       Impact factor: 14.808

5.  Broadened T-cell repertoire diversity in ivIg-treated SLE patients is also related to the individual status of regulatory T-cells.

Authors:  Nuno Costa; Ana E Pires; Ana M Gabriel; Luiz F Goulart; Clara Pereira; Bárbara Leal; Ana C Queiros; Wahiba Chaara; Maria F Moraes-Fontes; Carlos Vasconcelos; Carlos Ferreira; Jorge Martins; Marina Bastos; Maria J Santos; Maria A Pereira; Berta Martins; Margarida Lima; Cristina João; Adrien Six; Jocelyne Demengeot; Constantin Fesel
Journal:  J Clin Immunol       Date:  2012-10-14       Impact factor: 8.317

6.  Adenosine A2A Receptor Deletion Blocks the Beneficial Effects of Lactobacillus reuteri in Regulatory T-Deficient Scurfy Mice.

Authors:  Baokun He; Thomas K Hoang; Dat Q Tran; Jon Marc Rhoads; Yuying Liu
Journal:  Front Immunol       Date:  2017-12-06       Impact factor: 7.561

7.  Resetting microbiota by Lactobacillus reuteri inhibits T reg deficiency-induced autoimmunity via adenosine A2A receptors.

Authors:  Baokun He; Thomas K Hoang; Ting Wang; Michael Ferris; Christopher M Taylor; Xiangjun Tian; Meng Luo; Dat Q Tran; Jain Zhou; Nina Tatevian; Fayong Luo; Jose G Molina; Michael R Blackburn; Thomas H Gomez; Stefan Roos; J Marc Rhoads; Yuying Liu
Journal:  J Exp Med       Date:  2016-12-19       Impact factor: 14.307

Review 8.  A scoping review and proposed workflow for multi-omic rare disease research.

Authors:  Katie Kerr; Helen McAneney; Laura J Smyth; Caitlin Bailie; Shane McKee; Amy Jayne McKnight
Journal:  Orphanet J Rare Dis       Date:  2020-04-28       Impact factor: 4.123

Review 9.  Patterns of Allergic Sensitization in High IgE Syndromes.

Authors:  Monica G Lawrence
Journal:  Curr Allergy Asthma Rep       Date:  2015-12       Impact factor: 4.919

Review 10.  CD26 and Asthma: a Comprehensive Review.

Authors:  Juan J Nieto-Fontarigo; Francisco J González-Barcala; Esther San José; Pilar Arias; Montserrat Nogueira; Francisco J Salgado
Journal:  Clin Rev Allergy Immunol       Date:  2019-04       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.